STAT

MARCH 26, 2024

A new study of hospitals’ charity care spending suggests nonprofit hospitals really aren’t that different from their for-profit counterparts. One major benefit of being a nonprofit hospital is receiving tax exemptions on property taxes, income taxes, and sales taxes. Experts told STAT that implies a “social contract” with taxpayers, where these hospitals will help take care of the most vulnerable.

Hospitals 349

Hospitals 349

PharmaVoice

MARCH 26, 2024

A vastly underdiagnosed rare disease presents a challenge to Alnylam’s commercial team, but a family health road trip has patients talking about their hereditary risk.

147

147

STAT

MARCH 26, 2024

Troubled hospital operator Steward Health Care, grappling with a financial crisis that’s engulfed its eight Massachusetts hospitals, has moved to shore up its finances by striking a deal to sell its nationwide physician network to insurance giant UnitedHealth’s Optum Care unit. The proposed sale of the doctors group, called Stewardship Health, is part of Steward’s plan to bolster its national system of 33 hospitals after the Dallas-based company last year fell behind in payi

Hospitals 332

Hospitals Documentation 332

PharmaVoice

MARCH 26, 2024

After his first biotech startup was sold off in parts, Sharei is applying the lessons he’s learned to a new company with a different business model.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MARCH 26, 2024

The Food and Drug Administration is expected to approve Merck’s drug to treat a rare lung disorder called pulmonary arterial hypertension on Tuesday, making available a novel treatment for a deadly condition that’s long been challenging to treat. In a large trial published last year, the drug, called sotatercept, exceeded expectations in significantly increasing the distance that patients could walk and cutting the risk that their condition would worsen, that they would die, and th

305

305

Express Pharma

MARCH 26, 2024

Chandru Chawla, a pharma veteran writes an open letter to those CEOs of Pharmaceutical companies who have NOT purchased Electoral Bonds and have NOT made political donations through other means Dear Pharma CEO who did NOT make political donations Compliments from an ordinary soon-to-be senior citizen and a consumer of medicines. Recently, ordinary folks like me have been bombarded with this alleged scam being referred to as Chanda Do Dhanda Lo.

Pharmaceutical Companies 143

Pharmaceutical Companies Pharmaceutical Companies Hospitals 143

pharmaphorum

MARCH 26, 2024

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of underlying genetic mutations.

128

128

STAT

MARCH 26, 2024

Viking Therapeutics said Tuesday that its closely watched oral obesity drug had succeeded in an early-stage trial and that it planned to advance the medicine into the next phase of development.   The top-line results released Tuesday were only from a Phase 1 study, which primarily focuses on a drug’s safety. But Viking said that in the study, its medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues.

286

286

pharmaphorum

MARCH 26, 2024

As Women’s History Month comes to its final week, today’s podcast sees web editor Nicole Raleigh in conversation with Debra Weiss, COO of the Bill & Melinda Gates Medical Research Institute (Gates MRI), discussing her role as a female leader in the leader and the non-profit organisation’s work in developing novel biomedical interventions and lessening the burden of disease in LMICs.

115

115

STAT

MARCH 26, 2024

It’s time to acknowledge when a law intended to right an egregious wrong has become harmful — and change it. That’s the case for a law that requires people covered by Medicaid to wait at least 30 days after signing a consent to sterilization form to actually undergo the procedure. But there’s no waiting period for people covered by private insurance.

Hospitals 277

Hospitals 277

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

MARCH 26, 2024

Aduhelm (aducanumab) and Leqembi are examples of controversial drugs that faced challenges with FDA approval. Learn more about the expensive failure to launch of these medications.

112

112

STAT

MARCH 26, 2024

The U.S. Food and Drug Administration’s oversight of clinical research in hospitals and clinics has fallen considerably in recent years, due to disruptions caused by the Covid pandemic and challenges finding and keeping investigators, according to a new report by the U.S. Government Accountability Office. In 2022, the health regulator inspected 537 hospitals and clinics that were conducting studies of medicines for which drug manufacturers were seeking approvals.

Hospitals 268

Hospitals 268

pharmaphorum

MARCH 26, 2024

Nuvation Bio speeds up its path to becoming a commercial-stage biotech with a deal to acquire AnHeart Therapeutics and its late-stage lung cancer therapy taletrectinib

109

109

STAT

MARCH 26, 2024

Contemporary paintings by artists who have overcome homelessness or disabilities greet visitors in the lobby. Upstairs in the cafeteria, employees order lunches served by local restaurants, including barbecued pulled pork sandwiches from Pennypacker’s. On the top floor, workers can savor a panoramic view of the Seaport District and downtown Boston.

Drug Development 229

Drug Development 229

The Pharmacist

MARCH 26, 2024

Artificial intelligence (AI) could be ‘incredibly useful’ to monitor polypharmacy, pharmacy minister Dame Andrea Leadsom has said. Speaking as part of the Health and Social Care Committee's pharmacy inquiry, Dame Andrea suggested using AI during medicine reviews could help ensure health professionals are not 'overloading somebody unnecessarily' with medications.

105

105

STAT

MARCH 26, 2024

The European Commission has opened a formal antitrust investigation to determine whether Zoetis, one of the largest purveyors of medicines for dogs and cats, breached European Union competition rules by preventing the launch of a competing novel medicine that is used to treat chronic pain in canines. The company sells the first and only monoclonal antibody, called Librela, that is available to treat pain stemming from osteoarthritis suffered by dogs.

223

223

Community Pharmacy

MARCH 26, 2024

Vaccinations are among the most powerful tools modern medicine provides for public health. It’s estimated that before 2040, as many as 50 million deaths will be prevented by their protection, and whether it’s measles, hepatitis, or COVID-19 and its variants, vaccines save lives around the world. While vaccines give immediate protection to the individual, they also play an invaluable role within the larger community and public health sphere.

Vaccines 105

Vaccines Community Pharmacies Hospitals 105

STAT

MARCH 26, 2024

New biotech newsletter launching this Thursday.  Don’t miss out. Hello, everyone. Damian here with a look at a pivotal FDA approval, good news for a small biotech company, and why not all buyouts are worth writing home about.

Drug Pricing 212

Drug Pricing Drug Development 212

BioPharma Dive

MARCH 26, 2024

Merck is couting on Winrevair, which it acquired by buying Acceleron Pharma, to help soften the blow when Keytruda loses patent protection later this decade.

112

112

STAT

MARCH 26, 2024

Rise and shine, everyone, another busy day is on the way. How so? The evidence presented itself early this morning as the official mascots dashed about the grounds to bark about passersby, and a steady parade of driving machines could be seen from our window. All of which is to say that a cup of stimulation is in order. Our choice today is blueberry muffin.

Drug Pricing 202

Drug Pricing Insurance Coverage and Processing Diabetes Pharmaceutical Companies 202

Express Pharma

MARCH 26, 2024

Sanofi India and Cipla announced an exclusive partnership for distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India. As a part of this partnership, Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium, a leading brand in the anti-epileptic medication category. While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India and internationally, Cipla w

104

104

pharmaphorum

MARCH 26, 2024

MSD’s Winrevair (sotatercept) has become the first FDA-approved therapy for PAH that addresses the underlying mechanism behind the disease rather than its symptoms

108

108

BioPharma Dive

MARCH 26, 2024

The results are from a small Phase 1 study, but suggest Viking’s oral GLP-1 drug may not come with high rates of gastrointestinal side effects.

114

114

Express Pharma

MARCH 26, 2024

AstraZeneca Pharma India has received permission to import for sale and distribution of Trastuzumab deruxtecan lyophilised powder for concentrate for solution for infusion 100mg from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India for two additional indications. The new indications are: HER2-low metastatic breast cancer : Trastuzumab deruxtecan is now indicated for the treatment of adult patients with unresectable or metastatic

Chemotherapy 103

Chemotherapy 103

pharmaphorum

MARCH 26, 2024

Get live coverage of the latest updates and developments from Day 1 of Reuters Pharma USA 2024. Stay informed with real-time news and insights from the event.

110

110

Pharmaceutical Commerce

MARCH 26, 2024

A study of patients with the long-term conditions who are required to switch to high-deductible health plans could potentially be more likely to experience diabetes complications than those who stay in standard insurance plans.

Diabetes 102

Diabetes 102

pharmaphorum

MARCH 26, 2024

AstraZeneca’s Ultomiris has been approved by the FDA to treat rare autoimmune disease neuromyelitis optica spectrum disorder (NMOSD), six months after an earlier application was turned down with a request for changes to the risk evaluation and mitigation strategy (REMS) for the drug.

102

102

Express Pharma

MARCH 26, 2024

First live equity-for-investment bidding, for funding upto Rs 5 Crore/USD 540,000 for nutraceuticals innovators, will be streamed exclusively through the Boardroom series channel on the Express Pharma and Nutrify C Suite websites As the global dietary supplements market burgeons, poised to escalate from USD 148.8 billion in 2021 to an estimated USD 283 billion by 2030 (growing at a CAGR of 7.4 per cent from 2022 to 2030, according to Skyquest Technology), India emerges as a critical player in th

98

98

pharmaphorum

MARCH 26, 2024

Just four months after ending an 18-year stint as chief executive of BioMarin, Jean-Jacques Bienaimé has been named chairman of Owkin, a specialist in applying artificial intelligence to the discovery and development of drugs and diagnostics. Owkin said Bienaimé will help to grow the company, including taking it through its next fundraising round and expanding its drug discovery, drug development and diagnostics capabilities.

Drug Development 101

Drug Development 101

European Pharmaceutical Review

MARCH 26, 2024

Moderna’s next-generation COVID-19 vaccine mRNA-1283 demonstrated a higher immune response against SARS-CoV-2, interim results from the company’s Phase III trial show. These findings were based on data comparing the treatment to mRNA-1273.222 (Spikevax ® ), Moderna’s licensed vaccine for the condition. “We are excited to announce our fourth infectious disease vaccine programme with positive Phase III data,” stated Stéphane Bancel, Chief Executive Officer of Moderna. “mRNA

Vaccines 93

Vaccines Immunity Immunization 93

BioPharma Dive

MARCH 26, 2024

After his first biotech startup was sold off in parts, Sharei is applying the lessons he’s learned to a new company with a different business model.

99

99

Pharma Times

MARCH 26, 2024

According to the World Health Organization, TB is responsible for over one million annual deaths

116

116

Pharmaceutical Technology

MARCH 26, 2024

The US FDA has approved Alexion’s Ultomiris to treat adults with AQP4 Ab+ neuromyelitis optica spectrum disorder (NMOSD).

102

102

Pharma Times

MARCH 26, 2024

The Companion+ Mobile Safety App will be rolled out to a further 115 users within the UK and US

105

105

Outsourcing Pharma

MARCH 26, 2024

Under the agreement, Closed Loop Medicine â a leading TechBio company â and pharmaceutical company, Teva UK, will investigate opportunities to use Closed Loop Medicineâs proprietary software as a medical device (SaMD) technology platform.

Pharmaceutical Companies 79

Pharmaceutical Companies Pharmaceutical Companies 79